Abstract. An immunohistochemical study using antisera against proline rich salivary peptide P-C and insulin, glucagon, somatostatin and pancreatic polypeptide antisera was carried out on the foetal pancreas at different stages and on the newborn infant's, infant's, child's and adult pancreas to examine the time at which salivary peptide P-C like immunoreactivity appeared in the human pancreas. Salivary peptide P-C like immunoreactive cells first appeared as a few scattered cells in the foetal pancreas after 16 weeks of gestation and gradually increased in numbers during gestation. The cells corresponded only to insulin immunoreactive cells in the foetal, newborn infant's, infant's, child's and adult pancreas.
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Only some of the insulin immunoreactive cells in the foetal pancreas contained salivary peptide P-C like immunoreactivity while the majority of those in the infant's pancreas and all those in the child's and adult pancreas did so. The findings, together with the fact that the full sequence of salivary peptide P-C is identical to the COOH-terminal 44 amino acid residues of Salivary Protein C, led to the possibility that peptide P-C like immunoreactivity in the human pancreatic B-cells was not a moiety of the precursor of insulin and pro-insulin, but a moiety of Salivary Protein C. It has been suggested that, in saliva, Salivary Protein C aids in maintenance of the calcium concentration. Based on the hypothesis that peptide P-C like immunoreactivity in the human pancreatic B-cells may play some role in insulin release through the maintenance of the calcium concentration, the present finding seems to explain the fact that the mechanism for insulin release in the foetal pancreas is immature in spite of sufficient biosynthesis of insulin.
Recently, Isemura et al. (1979) isolated the salivary proline rich peptide P-C from human whole saliva and presented the primary structure of this pep¬ tide (Isemura et al. 1980) . Although the pathophysiological role of this peptide remained to be elucidated, its tissue distribution was recently de¬ monstrated by an indirect immunofluorescence technique using antisera against peptide P-C (Ito et al. 1983 ). Peptide P-C like immunoreactivity was present not only in the salivary glands but also in the pancreatic B-cells. As the antisera against pep¬ tide P-C did not have any cross-reactivity with other peptides, including insulin, human C-peptide, glu¬ cagon, somatostatin, pp and VIP, it was suggested that peptide P-C like immunoreactivity was present in the pancreatic B-cells independently of insulin and pro-insulin (Ito et al. 1983 ). Furthermore, peptide P-C like immunoreactivity was considered to play some role in the function of human pan¬ creatic B-cells, since it was localized only in the B-cells among the four kinds of cells in the islets. The idea made us interested in the time at which salivary peptide P-C like immunoreactivity ap¬ peared in the human panreatic B-cells, since it is well known that the mechanism for insulin release in the foetal pancreatic B-cells is immature in contrast to that in the adult pancreatic B-cells (Espinosa et al. 1970; Milneretal. 1972) .
In order to elucidate the time at which salivary peptide P-C like immunoreactivity appeared in the human foetal pancreas, an immunohistochemical study using antisera against peptide P-C was car¬ ried out on the foetal pancreas at different stages and on the newborn infant's, child's and adult pancreas.
Materials and Methods Antisera
Antisera against peptide P-C were produced in rabbits by injections of peptide P-C-BSA conjugates which had been prepared from isolated salivary peptide P-C and BSA by using glutaraldehyde. Details of the conjugation proce¬ dure and immunohistological character of the antisera have been reported previously (Ito et al. 1983 ).
Glucagon, somatostatin and pp antisera were also produced in rabbits. Preparation methods and the immunological character of these antisera have been re¬ ported elsewhere (Ito et al. 1981 (Ito et al. ,1982 (Ito et al. , 1983 Wong & Bennick (1980) recently presented the primary structure of a proline rich phosphoprotein named Salivary Protein C, which was isolated from human parotid saliva by Bennick & Connell (1971) . The protein consists of a single polypeptide chain of 150 residues, and its COOH-terminal 44 amino acid residues are identical to the full sequence of the salivary peptide P-C isolated from human whole saliva by Isemura et al. (1979) . The finding led us to question whether the peptide P-C like immunoreactivity detected in the human pancrea¬ tic B-cells is a salivary peptide P-C itself or a moiety of Salivary Protein C. In view of the present finding that peptide P-C like immunoreactivity does not appear to be a moiety of the precursor of insulin and pro-insulin, it seems unlikely that sali¬ vary peptide P-C itself is present in the human pancreatic B-cells, since two different peptides not produced from the same precursor are not thought to be present in the same endocrine cells. Thus, it seems reasonable to think that the peptide P-C like immunoreactivity in the human pancreatic B-cells may belong to a moiety of Salivary Protein C or to another unknown protein which has common antigenic determinants with salivary peptide P-C.
It has been reported that Salivary Protein C appears potentially capable of participating in the calcium exchange process in the oral cavity (Bennick & Cannon 1978) . If the peptide P-C like immunoreactivity detected in the human pancrea¬ tic B-cells belongs to a moiety of Salivary Protein C, it seems probable that the peptide P-C like immu¬ noreactivity in the human pancreatic B-cells may play some role in the calcium exchange process of pancreatic B-cells. This hypothesis together with the fact that calcium plays an important role in insulin release (Brisson et al. 1972; Valverde et al. 1979) leads to the possibility that the peptide P-C like immunoreactivity in the pancreatic B-cells may play some role in insulin release through the cal¬ cium exchange process of the pancreatic B-cells.
It is well known that the mechanism for insulin release in the foetal pancratic B-cells is immature up to the end of gestation (Pronina & Sapronove 1976) or for a few months after birth (Stimmler et Fig. 1 . Insulin (Figs, la and lc) and peptide P-C (Fig. lb) 
